T2 Biosystems's market cap is currently $2.80M. The company's EPS TTM is $-6.405; its P/E ratio is ―; T2 Biosystems is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 7.19M	$ 22.30M	$ 28.06M	$ 18.13M	$ 8.34M
Gross Profit	$ -8.17M	$ 1.17M	$ 7.36M	$ -3.15M	$ -8.43M
Operating Income	$ -49.66M	$ -55.51M	$ -42.97M	$ -41.36M	$ -52.06M
EBITDA	$ -43.88M	$ -55.20M	$ -41.13M	$ -38.49M	$ -48.30M
Net Income	$ -50.08M	$ -63.37M	$ -53.49M	$ -49.21M	$ -63.11M
Balance Sheet
Cash & Short-Term Investments	$ 15.69M	$ 10.33M	$ 32.24M	$ 42.19M	$ 11.03M
Total Assets	$ 34.80M	$ 34.39M	$ 60.54M	$ 79.08M	$ 28.49M
Total Debt	$ 49.50M	$ 59.22M	$ 57.15M	$ 55.77M	$ 44.77M
Net Debt	$ 33.81M	$ 48.89M	$ 34.90M	$ 38.98M	$ 33.74M
Total Liabilities	$ 62.83M	$ 74.36M	$ 73.44M	$ 70.35M	$ 62.49M
Stockholders' Equity	$ -28.04M	$ -39.97M	$ -12.90M	$ 8.73M	$ -34.01M
Cash Flow
Free Cash Flow	$ -48.33M	$ -50.97M	$ -39.33M	$ -44.02M	$ -46.12M
Operating Cash Flow	$ -48.14M	$ -50.63M	$ -38.87M	$ -43.22M	$ -45.36M
Investing Cash Flow	$ -192.00K	$ 9.66M	$ 24.79M	$ -36.26M	$ -761.00K
Financing Cash Flow	$ 52.69M	$ 29.05M	$ 20.54M	$ 85.61M	$ 6.35M

Currency in USD

T2 Biosystems Earnings and Revenue History

Income Statement >

T2 Biosystems Debt to Assets

Balance Sheet >

T2 Biosystems Cash Flow

Cash Flow >

T2 Biosystems Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing